X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs STERLING BIOTECH - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER STERLING BIOTECH PFIZER/
STERLING BIOTECH
 
P/E (TTM) x 24.2 -1.8 - View Chart
P/BV x 3.8 0.1 5,616.6% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 PFIZER   STERLING BIOTECH
EQUITY SHARE DATA
    PFIZER
Mar-16
STERLING BIOTECH
Dec-13
PFIZER/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs2,72411 25,942.9%   
Low Rs1,6113 47,382.4%   
Sales per share (Unadj.) Rs440.926.8 1,644.7%  
Earnings per share (Unadj.) Rs48.7-15.0 -325.6%  
Cash flow per share (Unadj.) Rs75.8-5.5 -1,387.0%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.954.9 843.5%  
Shares outstanding (eoy) m45.75267.87 17.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.90.3 1,896.3%   
Avg P/E ratio x44.5-0.5 -9,579.3%  
P/CF ratio (eoy) x28.6-1.3 -2,248.5%  
Price / Book Value ratio x4.70.1 3,697.2%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,1631,862 5,326.5%   
No. of employees `0002.91.4 213.4%   
Total wages/salary Rs m2,758547 504.3%   
Avg. sales/employee Rs Th6,981.75,303.3 131.6%   
Avg. wages/employee Rs Th954.5403.8 236.4%   
Avg. net profit/employee Rs Th771.1-2,959.0 -26.1%   
INCOME DATA
Net Sales Rs m20,1707,181 280.9%  
Other income Rs m85743 2,012.7%   
Total revenues Rs m21,0287,223 291.1%   
Gross profit Rs m4,310947 455.1%  
Depreciation Rs m1,2392,543 48.7%   
Interest Rs m54,377 0.1%   
Profit before tax Rs m3,923-5,931 -66.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794-1,924 -93.2%   
Profit after tax Rs m2,228-4,007 -55.6%  
Gross profit margin %21.413.2 162.0%  
Effective tax rate %45.732.4 141.0%   
Net profit margin %11.0-55.8 -19.8%  
BALANCE SHEET DATA
Current assets Rs m16,29914,335 113.7%   
Current liabilities Rs m7,59449,809 15.2%   
Net working cap to sales %43.2-494.0 -8.7%  
Current ratio x2.10.3 745.8%  
Inventory Days Days65403 16.2%  
Debtors Days Days26171 15.1%  
Net fixed assets Rs m8,62255,432 15.6%   
Share capital Rs m458268 170.8%   
"Free" reserves Rs m20,72213,935 148.7%   
Net worth Rs m21,18014,701 144.1%   
Long term debt Rs m259,478 0.3%   
Total assets Rs m29,13773,988 39.4%  
Interest coverage x755.5-0.4 -212,834.8%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.70.1 713.3%   
Return on assets %7.70.5 1,530.0%  
Return on equity %10.5-27.3 -38.6%  
Return on capital %19.0-6.4 -295.6%  
Exports to sales %0.125.9 0.2%   
Imports to sales %17.50.2 10,288.3%   
Exports (fob) Rs m121,860 0.6%   
Imports (cif) Rs m3,52612 28,899.2%   
Fx inflow Rs m521,860 2.8%   
Fx outflow Rs m14025 562.4%   
Net fx Rs m-881,835 -4.8%   
CASH FLOW
From Operations Rs m3,4361,719 199.9%  
From Investments Rs m-6,991-3,148 222.1%  
From Financial Activity Rs m-6191,426 -43.4%  
Net Cashflow Rs m-4,174-3 122,750.0%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 9.9 49.5%  
ADR/GDR % 0.0 16.9 -  
Free float % 23.7 39.3 60.3%  
Shareholders   85,207 21,482 396.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  ABBOTT INDIA  DR. DATSONS LABS  

Compare PFIZER With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 18, 2017 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS